Examining the Impact of Tampon Use on the Vaginal Microbiota
NCT03346759 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 28
Last updated 2018-08-23
Summary
The vaginal microbiota is the community of bacteria in the vagina. The composition of the vaginal microbiota (which bacteria are present and how many of each are present) is known to affect vaginal health and contribute to the development of bacterial vaginosis (the largest cause of vaginal discharge and malodor, and the most common vaginal disorder). It is also known that the composition of the vaginal microbiota changes across a menstrual cycle with the largest changes happening during a woman's period. However, it is not know how tampon use affects vaginal microbiota composition. This study is being done to learn what effect tampon use has on vaginal microbiota composition during a woman's period and between periods.
Conditions
- Vaginal Microbiota
Interventions
- DEVICE
-
Tampon A
24 Tampax Pearl Regular Tampons for use during a single menstrual period.
- DEVICE
-
Tampon B
24 Playtex Gentle Glide 360 Regular Tampons for use during a single menstrual period.
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Jason Bell, MD · University of Michigan
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-02-20
- Primary Completion
- 2017-09-11
- Completion
- 2017-09-11
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Treatment of Bacterial Vaginosis (BV) With Tinidazole
NCT00334633 ·Status: COMPLETED ·Phase: PHASE4
-
Human Microbiome and Healthcare Associated Infections - Nursing Home Dwelling Older Veterans
NCT04218799 ·Status: COMPLETED ·Phase: PHASE4
-
Dose Ranging Study of Metronidazole Vaginal Gel in the Treatment of Bacterial Vaginosis
NCT01055106 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment of Bacterial Vaginosis Prior to Active Labor and Infectious Morbidity
NCT03954990 ·Status: TERMINATED ·Phase: PHASE1
-
Study of the Composition and Bacterial Diversity of the Vaginal Microbiota in Healthy Versus Pathological Conditions (Bacterial Vaginosis) Using a Targeted Metagenomic Approach (RNA 16s)
NCT04989543 ·Status: COMPLETED ·Phase: NA
-
Will Lactobacillus Increase Cure Rate After Treatment of Bacterial Vaginosis and Chronic Vulvovaginal Candida
NCT02295579 ·Status: COMPLETED
-
Treatment Comparison of Antibiotics Versus Vaginal Lactic Acid in Non-pregnant Women With Acute Symptomatic Bacterial Vaginosis
NCT02042287 ·Status: COMPLETED ·Phase: PHASE4
-
Treatment of Bacterial Vaginosis Combined With Human Lactobacilli
NCT01245322 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy of Dalbavancin Versus Vancomycin in the Treatment of Catheter-Related Bloodstream Infections
NCT00057369 ·Status: UNKNOWN ·Phase: PHASE2
-
Use of Blue Light Emitting Diode in the Treatment of Women With Bacterial Vaginosis: a Clinical Trial
NCT03500107 ·Status: RECRUITING ·Phase: NA
-
Effect of Antibiotics on Urinary Microbiome
NCT04230746 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
Suppressive Antibacterial Therapy With Once-Weekly Secnidazole Granules to Prevent Recurrent Bacterial Vaginosis; A Pilot Study
NCT05033743 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Management of Vaginal Complaints: A Pilot Study Within a Practice-Based Research Network
NCT00503542 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Clinical Validation of the Molecular-Based GenePOC Carba Assay for the Detection and Differentiation of Carbapenemase Genes in Rectal Swab Samples.
NCT03680898 ·Status: UNKNOWN ·Phase: NA
-
Research on Vaginal Microbiota Evaluation Unified Standards Based on Gram Staining
NCT05997160 ·Status: UNKNOWN
-
Study of Omiganan 1% Gel in Preventing Catheter Infections/Colonization in Patients With Central Venous Catheters
NCT00231153 ·Status: COMPLETED ·Phase: PHASE3
-
Reduction of Bacteriuria in Subjects Practicing Intermittent Catheterization
NCT01143116 ·Status: COMPLETED ·Phase: NA
-
Disturbance of the Intestinal Microbiota by Temocillin vs Cefotaxime in Treatment of Febrile Urinary Tract Infections
NCT02959957 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of the Antimicrobial Effectiveness of an Antimicrobial Cloth
NCT03229759 ·Status: COMPLETED ·Phase: PHASE2
-
Vaginal Clindamycin Cream Plus Vaginal Probiotic for Bacterial Vaginosis
NCT03234517 ·Status: UNKNOWN ·Phase: PHASE2
-
The Effect of Clindamycin and a Live Biotherapeutic on the Reproductive Outcomes of IVF Patients With Abnormal Vaginal Microbiota
NCT05166746 ·Status: UNKNOWN ·Phase: PHASE2
-
Optimization of Bacterial Vaginosis Treatment in Women of Reproductive Age
NCT06458543 ·Status: RECRUITING ·Phase: PHASE4
-
Red Light Photobiomodulation and Topical Disinfectants
NCT05797818 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study of Antimicrobial Activity of Omiganan 1% Gel vs. Chlorhexidine 2% for Topical Skin Antisepsis in Healthy Adult Subjects
NCT00608959 ·Status: COMPLETED ·Phase: PHASE3
-
Vaginal Microbiome-host Interaction in Mesh Exposure After TVM Surgery
NCT05000112 ·Status: UNKNOWN